Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-15

FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves Aurobindo Pharma Limited's original application for Amlodipine and Olmesartan Medoxomil, a generic fixed-dose combination used to treat hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and olmesartan medoxomil (amlodipine and olmesartan medoxomil)

Snippet

ORIG AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)